Effect of Dutasteride on Bladder Wall Hypertrophy in Patients With Benign Prostatic Obstruction: A 24-Week Open-Label, Single-Arm Pilot Study.
Phase of Trial: Phase IV
Latest Information Update: 09 Dec 2009
At a glance
- Drugs Dutasteride (Primary)
- Indications Benign prostatic hyperplasia
- Focus Pharmacodynamics
- 08 May 2009 Actual number of patients (36) added as reported by ClinicalTrials.gov
- 08 May 2009 Actual end date (1 Apr 2009) as reported by ClinicalTrials.gov.
- 08 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.